Galectin Therapeutics Inc
Pharmaceutical company · Norcross, Georgia, United States · Nasdaq: GALT
Galectin Therapeutics Inc is a pharmaceutical company headquartered in Norcross, Georgia, United States. Its shares trade on Nasdaq under the ticker GALT. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2017.
Galectin Therapeutics at a glance
What does Galectin Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3 million sold (2017).
Frequently asked questions about Galectin Therapeutics
Where is Galectin Therapeutics headquartered?
Galectin Therapeutics Inc is headquartered in Norcross, Georgia, United States.
What does Galectin Therapeutics do?
Galectin Therapeutics Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Galectin Therapeutics a public company?
Yes. Galectin Therapeutics Inc trades on Nasdaq under the ticker GALT.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences